Team:UCL/Science/Bioprocessing

From 2014.igem.org

(Difference between revisions)
Line 231: Line 231:
<a style="float: right;margin-left:2%"><img src="
<a style="float: right;margin-left:2%"><img src="
https://static.igem.org/mediawiki/2014/d/d7/IMMOBILIZATION_MODULE.png
https://static.igem.org/mediawiki/2014/d/d7/IMMOBILIZATION_MODULE.png
-
" style="width: 120%;"></a>
+
" style="width: 100%;"></a>
-
<h4>A Convincing Case for Immobilisation</h4><br>The immobilized enzyme format boasts superior overall handling properties and operating efficiencies with respect to the alternative; a free floating system. It is characterized by the retention of a biologically active catalyst within a reactor or analytical system. The standard principle of biocatalyst immobilization involves an insoluble complex on a specialized module, facilitating the controlled enzymatic reaction of a permeating mobile phase. Whilst adopting the physical characteristics of the support matrix, enzymes/whole-cells retain their catalytic functionality. Below are some benefits of choosing to immobilize over a free-floating mode.  
+
<h4>A Convincing Case for Immobilisation</h4><br>The immobilised enzyme format boasts superior overall handling properties and operating efficiencies with respect to the alternative; a free floating system. It is characterised by the retention of a biologically active catalyst within a reactor or analytical system. The standard principle of biocatalyst immobilisation involves an insoluble complex on a specialised module, facilitating the controlled enzymatic reaction of a permeating mobile phase. Whilst adopting the physical characteristics of the support matrix, enzymes/whole-cells retain their catalytic functionality. Below are some benefits of choosing to immobilize over a free-floating mode.  
</p>
</p>
-
 
+
<p class="infoBlock1 cf">
 +
<a style="float: right;margin-left:2%"><img src="
 +
https://static.igem.org/mediawiki/2014/7/7d/Catalyst_Retention.png
 +
" style="width: 100%;"></a>
 +
<b>3-D sketch of the integrated treatment process highlighting the immobilization module</b> <br>The immobilized enzyme format boasts superior overall handling properties and operating efficiencies with respect to the alternative; a free floating system. It is characterized by the retention of a biologically active catalyst within a reactor or analytical system. The standard principle of biocatalyst immobilization involves an insoluble complex on a specialized module, facilitating the controlled enzymatic reaction of a permeating mobile phase. Whilst adopting the physical characteristics of the support matrix, enzymes/whole-cells retain their catalytic functionality. Below are some benefits of choosing to immobilize over a free-floating mode.
 +
</p>

Revision as of 01:08, 17 October 2014

Goodbye Azodye UCL iGEM 2014

Sustainable Bioprocessing

Module operation


After the fermentation stage, the E. coli biomass is dispersed in a liquor also containing various byproducts. A concentration step could be beneficial to reduce volumes in the next stage. However, capital costs of such unit operations would not be attractive to potential dyeing companies deciding to acquire the entire system. The subsequent modules are equipped to handle large volumes and operate in continuous-flow mode with intermittent discharges. By controlling residence time and operating flow rates, it will be possible to achieve a cell recovery deemed efficient. These will be then immobilized onto the surface of the plates within the modules. There exists a wide range of immobilization strategies used for biological wastewater treatment and this is what gives the unit its modular character. By supporting a number of immobilization methods without changing the hardware, the module allows for the enzymatic breakdown of a wide range of recalcitrant chemicals that might be financially and environmentally costly to treat using conventional methods. (more to come)


Design of immobilization unit

Top view of the module with Azodye feed pipe (red) and aeration inlets for the plates (green).

Our Design Process

We will use rapid polymer prototyping techniques to generate microfluidic chips that will allow us to test our reaction and aid in the construction of a realistic bioprocess, which can be successfully scaled-up for industrial use. As we optimise and change our bioprocess, we can also quickly design new microfluidic chips that can mimic its development on a micro-scale. For example, it is our goal to integrate multiple downstream steps, such as chromatography, in order to isolate potential useful products. Demonstrating this in a microfluidic system is less time-consuming and far more cost effective than doing so at a larger scale.


For our microfluidic bioreactor, we will be using a magnetic free floating bar as our mixing system. This is an effective method of mixing at a microfluidic scale, as demonstrated in the video on the right. This video is of a microfluidic chemostat bioreactor designed by Davies et al. 2014 UCL, using a free-floating bar to mix two dyes.



Above are some examples of the microfluidics devices developed by our team for use in the lab at the UCL ACBE. The devices are initially designed using AutoCAD (2D and 3D computer-aided design software), once the designs are finalised they can be 3D-printed using the facilities provided by the UCL Institute of Making and UCL ACBE; allowing our bioprocess and laboratory team to experiment and improve designs.


An example of one of our microfluidic devices designed on AutoCAD can be downloaded here. This device utilises the basic concept of mixing the cells and dyes, producing a single output stream; much alike to the bioprocessing concept. During the course of designing the microfluidic device, several key considerations must be taken into account: ability to withstand high pressure without leakage; materials of construction to be inert and transparent; size constraints of inlet and outlet piping; ability to accurately 3D-print the device.


Why Bioprocessing?

Bioprocess engineering is a conglomerate of fields and is extensively employed to optimize a variety of production processes. In order to cope with market forces, industries for example the pharmaceutical, have had to considerably improve their bioprocessing tools and techniques. As a result a range of novel process alternatives have been developed to harness product-specific properties, each bearing benefits, disadvantages and costs. While these can be used to drive financial returns, biological processing is becoming a gateway to eco-friendly alternatives for the treatment of recalcitrant wastewater such as industrial effluents. By providing more flexibility in supporting efficient degradation of toxic compounds and having lower operating costs, the biological treatment process brings forward key advantages over it's traditional counterpart.
A typical bioprocess involves the fermentation of a stock culture (e.g. E. coli) at a small scale which is subsequently scaled up to suitable production capacities. The products from the fermentative stages are consequently separated and purified using a variety of unit operations designed to exploit the orthogonal properties of desired products. These can then be formulated into their ultimate delivery form.




Flowsheet with unit operations for a typical bioprocess

The design of a successful bioprocess requires careful analysis of the many factors that impact choice of design parameters and process variables. It is crucial to consider the cost of the process at each stage to assess it's large scale feasibility.

Let's look at an example bioprocess
1. Upstream: Production bioreactor preceded by small-scale seed fermenters
2. Downstream: constitutes of three main stages
- Recovery relates to primary unit operations i.e. centrifugation and filtrations. The main goal is to concentrate the desired compound within the process stream by reducing volumes and removing fermentation byproducts.
- Purification involves unit operations such as chromatography, crystallization and ultrafiltration. The final stages are necessary to ensure purity requirements are met.
- Formulationinvolves the integrating of the product into the target delivery route followed by packaging and storage.

Contact Us

University College London
Gower Street - London
WC1E 6BT
Biochemical Engineering Department
Phone: +44 (0)20 7679 2000
Email: ucligem2014@gmail.com

Follow Us